UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000019357
Receipt number R000022303
Scientific Title A phase II trial of CHOP-14 with Mogamulizumab for untreated elderly patients with CCR4 positive adult T-cell leukemia/lymphoma
Date of disclosure of the study information 2015/10/19
Last modified on 2022/08/22 09:34:59

No. Disposal Last modified on Item of update
1 Insert 2015/10/15 13:36:12
2 Update 2015/10/19 18:32:10 Recruitment status
3 Update 2016/08/06 19:15:17 Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Name of primary person or sponsor
Institute
Organization
4 Update 2016/08/06 19:16:40 Condition
Condition
5 Update 2017/08/05 10:40:32 Recruitment status
6 Update 2019/01/24 14:59:08 Email
Email
Name of primary person or sponsor
Institute
Institute
Organization
Organization
Organization
Category of Funding Organization
Email1
Institutions
7 Update 2019/01/24 15:01:56 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
8 Update 2019/04/18 20:48:44 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
Name of primary person or sponsor
Organization
Organization
Address
Address
Tel
Email
Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
9 Update 2019/04/18 20:53:46 Date of IRB
10 Update 2020/10/18 09:05:54 Organization
Organization
Institutions
11 Update 2020/12/14 22:55:03 Recruitment status
12 Update 2021/10/28 04:22:37 Number of participants that the trial has enrolled
13 Update 2022/08/22 09:34:59 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded